A site-specific controlled-release system for metformin
- 1 May 2005
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 57 (5) , 565-571
Abstract
Oral absorption of the antihyperglycaemic agent metformin hydrochloride (MF-HCl) is confined to the upper part of the intestine, therefore rational controlled-release formulations of this drug should ensure a complete release during transit from stomach to jejunum. The aim of this study was the preparation of a system able to sustain release of high MF-HCl doses in compliance with the above requirement. Matrices (6 mm diameter; 50 mg weight) comprising varying drug-Precirol ATO 5 ratios were prepared by compression. The matrix containing 70% drug was coated on one face with Eudragit L100–55. Drug release to simulated gastric (SGF), jejunal (SJF) and ileal (SIF) fluids in sequence was studied using a modified USP rotating basket method. Release depended on drug load whereas it was independent of dissolution medium pH and hydrodynamics. Release kinetics were of √t type and were determined by drug diffusion in aqueous pores created in the matrix by drug dissolution. An equation correlating rate-determining factors was developed, whereby the release pattern could be optimized. The half-coated matrix started release in SGF and completed it in SJF. The half-coated matrix, synchronizing drug release and matrix transit across the small intestine, may improve drug bioavailability and reduce side effects.Keywords
This publication has 17 references indexed in Scilit:
- In vitro evaluation of a system for pH-controlled peroral delivery of metforminJournal of Controlled Release, 2002
- Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenateEuropean Journal of Pharmaceutics and Biopharmaceutics, 2001
- Pharmacokinetics of Metformin Gastric‐Retentive Tablets in Healthy VolunteersThe Journal of Clinical Pharmacology, 2001
- Polyoxyethylene-poly(methacrylic acid-co-methyl methacrylate) compounds for site-specific peroral deliveryInternational Journal of Pharmaceutics, 2000
- Gastrointestinal transit of a matrix tablet formulation: comparison of canine and human dataInternational Journal of Pharmaceutics, 1993
- The Use of Precirol® to Prepare Sustained Release Tablets of Theophylline and Quinidine GluconateDrug Development and Industrial Pharmacy, 1990
- Pharmacokinetic-Pharmacodynamic Relationships of Oral Hypoglycaemic AgentsClinical Pharmacokinetics, 1989
- Mass transport Phenomena and Models: Theoretical ConceptsJournal of Pharmaceutical Sciences, 1974
- Investigation of Factors Influencing Release of Solid Drug Dispersed in Inert MatricesJournal of Pharmaceutical Sciences, 1965
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963